Earnings History Data for Xenetic Biosciences (XBIO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Xenetic Biosciences
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications. Additionally, Xenetic is leveraging PolyXen(TM), its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. PolyXen(TM) has demonstrated its ability to improve the half-life and other pharmacological properties of next-generation biologic drugs. The Company has an exclusive license agreement with Takeda Pharmaceuticals Co. Ltd. in the field of coagulation disorders and expects to earn royalty payments under this agreement.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21-03-2024 | PM | XBIO | Xenetic Biosciences | 7.00 | -0.77 | -0.87 | 0.00 | Xenetic Biosciences reports FY results [3/22/2024 8:14 AM] |
3.96 | 0.01 (0.35%) |
0.0 | 0.0 (0.00%) |
2.55 - 5.97 | 2,686 | 10,000 | 0 | ||
| 10-11-2023 | PM | XBIO | Xenetic Biosciences, Inc. | 4.68 | -0.69 | -1.12 | -0.60 | Xenetic Biosciences reports Q3 results [11/10/2023 9:18 AM] |
2.91 | -0.04 (-1.36%) |
0.0 | 0.0 (0.00%) |
2.40 - 7.50 | 5,214 | 0 | 0 | ||
| 10-11-2022 | PM | XBIO | Xenetic Biosciences | 6.00 | -0.06 | -0.18 | 0.00 | Xenetic Biosciences GAAP EPS of -$0.06, revenue of $411.95M [11/10/2022 8:51 AM] |
0.4069 | 0.02 (4.33%) |
0.39 | 0.0 (0.00%) |
0.36 - 1.76 | 51,645 | 70,000 | 550 | ||
| 12-08-2022 | PM | XBIO | Xenetic Biosciences, Inc. | 5.29 | -0.19 | -0.12 | -0.13 | Xenetic Biosciences reports Q2 results [8/12/2022 8:29 AM] |
0.9196 | 0.04 (4.50%) |
0.88 | -0.01 (-1.11%) |
0.45 - 4.44 | 17,102 | 60,000 | 396 | ||
| 23-03-2022 | PM | XBIO | Xenetic Biosciences, Inc. | 6.42 | N/A | -0.15 | -0.15 | Xenetic Biosciences GAAP EPS of -$0.55, revenue of $1.16M [3/23/2022 9:19 AM] |
1.09 | 0.04 (3.81%) |
1.04 | -0.01 (-0.95%) |
0.85 - 5.68 | 256,558 | 137,625 | 9,100 | ||
| 12-11-2021 | PM | XBIO | Xenetic Biosciences, Inc. | 10.89 | -0.13 | -0.12 | 0.27 | Xenetic Biosciences EPS misses by $0.01, beats on revenue [11/12/2021 8:34 AM] |
1.72 | 0.05 (2.99%) |
1.69 | 0.02 (1.19%) |
0.82 - 5.85 | 230,526 | 210,000 | 15,952 | ||